MRI 能否近乎确定地诊断前列腺癌
该研究纳入880例疑诊前列腺癌并接受增强多参数MRI患者,其中251例MRI Likert 4-5分者由4位资深放射科医生回顾性分级诊断确定性。共识中79例达到「99%确定」,活检者100%存在显著肿瘤;45例「90%确定」者中98%有显著肿瘤。
要点
- MRI判为「99%确定」且Likert 4-5分者,活检全部为GG2及以上显著肿瘤。
- 「90%确定」组仅1例活检为GG1,其余98%为显著肿瘤。
- 确定性低于90%组中42%有显著肿瘤,仅7%为GG3及以上。
核心结论
- 存在一组患者可依据MRI表现近乎确定诊断前列腺癌,未来或可免活检直接治疗。
研究设计与样本
- 回顾性研究,880例连续疑诊前列腺癌患者接受增强多参数MRI,平均PIQUAL 1评分3.6/5。
- 251例当时MRI判读Likert 4-5/5者纳入研究组,由4位资深放射科医生在知晓PSA和年龄条件下回顾性评分。
- 诊断确定性分为「99%确定」「90%确定」「<90%确定」三级,分歧时经讨论达成共识。
- 组织学参考标准为经会阴靶向活检,显著肿瘤定义为Gleason分级组GG2及以上。
诊断标准与关键数值
- 共识中79例(占单站门诊就诊者9%,占当时MRI Likert 4-5分患者30%)被判定为「99%确定」。
- 「99%确定」组中69例接受活检,100%为显著肿瘤,其中72%为Gleason GG3或更高。
- 「90%确定」组共45例,41例接受活检,40例(98%)为显著肿瘤,1例为GG1肿瘤。
- 「<90%确定」组中42%存在显著肿瘤,其中仅7%为GG3或更高。
临床应用与阅片要点
- 当资深放射科医生对MRI阳性病灶达到「99%确定」时,可高度信赖其对应显著前列腺癌。
- Likert 4-5分且诊断确定性达90%以上者,显著肿瘤概率极高,活检阴性时需复核影像与取样。
- 确定性低于90%的Likert 4-5分病灶仍可能为GG2显著肿瘤,不宜直接省略活检。
局限性
- 回顾性设计,放射科医生评分时已获知PSA和年龄,可能存在信息偏倚。
- 并非所有患者均接受活检,部分「99%确定」与「90%确定」病例缺乏组织学验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We hypothesised that it was possible for radiologists to identify scans as positive for tumour with near certainty on MRI alone.
METHODS: 880 consecutive patients attended our clinic for suspected prostate cancer and underwent enhanced multiparametric MRI (with a mean PIQUAL 1 score of 3.6/5). Of these, 251 were scored Likert 4-5/5 on MRI and were the study group. 4 experienced radiologists retrospectively scored the 251 scans, knowing PSA and age, to one of three levels of certainty: '99% sure', '90% sure' and '< 90% sure'. If their scores were different then a consensus opinion was achieved by discussion. Histology was by targeted transperineal biopsy. Significant tumour was considered Gleason Grade Group (GG) 2 and above.
RESULTS: In consensus, 79 patients (9% of those presenting to the one stop clinic and 30% of patients scoring 4-5/5 on the MRI read at the time) were scored positive with a '99% sure' level of certainty. Of these, 69 were biopsied and all (100%) had significant tumour, with 72% Gleason GG3 or higher. 45 patients were scored positive to the '90% sure' level. Of these 41 underwent biopsy and 40 (98%) had significant tumour (the one negative patient had GG1 tumour). In the '< 90% sure group, 42% had significant tumour, of which only 7% was GG3 tumour or higher.
CONCLUSION: There is a group of patients in whom prostate cancer is close to certain based on MRI findings. In future this may enable treatment without the need for biopsy.
引用
- Cummings, Allen, Dickinson, et al. Can prostate cancer be diagnosed with near certainty on MRI? Eur J Radiol. 2026. PMID: 42531699. doi:10.1016/j.ejrad.2026.113107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。